Diagnostic Accuracy of Fine Needle Aspiration in Parotid Tumors
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00534612|
Recruitment Status : Unknown
Verified January 2003 by National Institute of Cancerología.
Recruitment status was: Recruiting
First Posted : September 26, 2007
Last Update Posted : September 26, 2007
|Condition or disease||Intervention/treatment||Phase|
|Parotid Gland Neoplasms||Procedure: aspiration biopsy||Early Phase 1|
This is a prospective diagnostic test study. Inclusion criteria are all consecutive patients with parotid gland masses referred for treatment at our center, from January 2003 to December 2007.
The gold standard for the diagnosis of malignancy is the surgical pathology report of the parotidectomy specimen.
Cytologist and pathologist will be blind. Diagnostic accuracy is determinded by Bayesian analysis.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||150 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||Double (Investigator, Outcomes Assessor)|
|Official Title:||Accuracy of Fine Needle Aspiration Biopsy in the Pre-Operative Diagnosis of Malignancy in Patients With Parotid Gland Masses|
|Study Start Date :||January 2003|
|Estimated Study Completion Date :||December 2007|
fine needle aspiration biopsy of the parotid gland mass
Procedure: aspiration biopsy
fine needle aspiration biopsy of the parotid gland masses
- Diagnosis of malignancy [ Time Frame: three years ]
- Specific histopathologic diagnosis [ Time Frame: three years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00534612
|Contact: Jose F Carrillo, M.D.||+52 (55) 56280400 ext firstname.lastname@example.org|
|Contact: Luis F Oñate-Ocaña, M.D:||´52 (55) 56280400 ext email@example.com|
|National Cancer Institute||Recruiting|
|Mexico, D.f:, Mexico, 14080|
|Principal Investigator: Jose F Carrillo, M.D.|
|Principal Investigator:||Jose F Carrillo, M.D:||National Cancer Institute, Mexico|